Management & Regulatory

PCI Pharma Invests $365M in Advanced Drug Delivery Infrastructure
Management & Regulatory PCI Pharma Invests $365M in Advanced Drug Delivery Infrastructure

PCI Pharma Services has made a monumental $365 million investment to enhance its capabilities in the assembly and packaging of sophisticated drug-device combination products, particularly those involving injectable formats. This global Contract Development and Manufacturing Organization (CDMO) aims

Can Europe Overcome Challenges to Lead Biopharma Innovation Again?
Management & Regulatory Can Europe Overcome Challenges to Lead Biopharma Innovation Again?

Europe's rich heritage in pharmaceutical innovation has significantly shaped the global landscape. Yet, recent decades have seen this continent cede its leading position to the U.S. and witness emerging markets like China and India surge ahead. The question now is whether Europe can chart a path

Cryoport and SK pharmteco Join Forces to Advance Cell and Gene Therapy
Management & Regulatory Cryoport and SK pharmteco Join Forces to Advance Cell and Gene Therapy

In a significant move within the life sciences industry, Cryoport, Inc. and SK pharmteco have announced a strategic partnership focused on advancing cell and gene therapy. This collaboration aims to integrate logistics and manufacturing services for biotechnology and pharmaceutical companies,

How Is Sutro Biopharma Inc. Faring in the Current Market Climate?
Management & Regulatory How Is Sutro Biopharma Inc. Faring in the Current Market Climate?

Sutro Biopharma Inc. (NASDAQ: STRO) has experienced a dynamic market journey characterized by several key financial metrics, analyst ratings, and insider transactions. This article delves into the company’s recent market performance, aiming to provide investors with a comprehensive understanding of

Biopharmaceutical Contract Manufacturing Market to Surge by 2032
Management & Regulatory Biopharmaceutical Contract Manufacturing Market to Surge by 2032

The global biopharmaceutical contract manufacturing market is anticipated to experience significant growth from 2024 to 2032. This market's expansion is driven by continuous technological innovations, increased research and development (R&D) investments, and strategic collaborations among key

How Did KBI Biopharma Resolve a Pink Media Crisis in GMP Production?
Management & Regulatory How Did KBI Biopharma Resolve a Pink Media Crisis in GMP Production?

KBI Biopharma, a prominent contract development and manufacturing organization (CDMO), encountered a critical issue during a GMP (Good Manufacturing Practice) production run. An unexpected pink discoloration appeared in the cell culture media, a crucial component for biologic drug production. The

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later